REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in preclinical models of asthma, acute lung inflammation and dermatitis Efficacy comparable to anti-IL-4/IL-13 antibody combination control with a favorable tolerability profile in preclinical models Being advanced under a strategic partnership with Sanofi, where Recludix has […]

(NASDAQ:SSTI), FREMONT, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology provider, announced today that Alan Stewart, Chief Financial Officer, will participate virtually in the 28th Annual Needham Growth Conference on Thursday, January 15, 2026. Investors interested in scheduling either one-on-one or group meetings with management should contact

PARAMUS, N.J., Dec. 16, 2025 (GLOBE NEWSWIRE) — Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that Chairman and Chief Executive Officer, Pedro Lichtinger, will present a company overview and provide an update on its lead program, STAR-LLD, at Biotech Showcase 2026, which

(NASDAQ:RCAT), SALT LAKE CITY, Dec. 16, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today announced that Jeff Thompson, Chief Executive Officer, and Christian Morrison, Chief Financial Officer, will present at the Needham Growth

New MemMachine-powered agents, model and framework Integrations, and advanced memory features MemVerge, a leader in AI memory software, today announced a major expansion of its MemMachine AI memory system, unveiling advanced memory capabilities, streamlined developer tools, deeper ecosystem integrations, and a rapidly growing portfolio of third-party agents built with MemMachine inside. This release strengthens MemVerge's

ZS has been named a Leader in the inaugural IDC MarketScape: Worldwide Life Sciences R&D AI (Including GenAI) in Clinical Trials 2025 Vendor Assessment (doc # US53704325, August 2025). This recognition is seen as especially important as more life sciences companies pursue in silico clinical trials. https://mma.prnewswire.com/media/2840508/ZS_Logo.jpg Why ZS was named a Leader in the

Laser by Aleya, a provider of New York laser and electrolysis hair removal services, has expanded its service approach to acknowledge the growing connection between skincare and mental health, offering clients supportive consultations that factor in emotional well-being alongside visible skin concerns. The initiative aligns with Laser by Aleya's continued investment in women's wellness and

AdultLevel IV Trauma Center Accreditation has been granted to five additional hospitals in Pennsylvania effective January 1, 2026. — Geisinger Medical Center Muncy – Muncy, PA — Indiana Regional Medical Center – Indiana, PA — Mount Nittany Medical Center – State College, PA — St. Luke's Hospital – Easton Campus – Easton, PA — Wellspan

TheTSC Alliance Endowment Fund, a supporting organization of the TSC Alliance, has invested in Aeovian Pharmaceuticals as part of their Series B financing in support of their Phase 2 trial of AV078, a first-in-class CNS-penetrant selective mTORC1 inhibitor in tuberous sclerosis complex (TSC). https://mma.prnewswire.com/media/1508841/Tuberous_Sclerosis_Alliance_Logo.jpg “This equity stake is in line with the TSC Alliance Endowment

With professional quality output, high efficiency, and flexible creative scenarios, the new Vidu Agent enables users to generate complete 15 to 30 second video with a single click. ShengShu Technology, a global leader in multimodal generative AI, today announced the launch of Vidu Agent, a one-click professional video creation tool designed to turn images into